Personalized healthcare company Accolade Inc (NASDAQ:ACCD) stock is trading slightly higher after the company announced ...
Barclays analyst Stephanie Davis maintained a Hold rating on Accolade (ACCD – Research Report) today and set a price target of $5.00.
Shares in Accolade Inc (NASDAQ:ACCD) jumped after the company reported a narrower-than-expected loss and strong margin growth for the fiscal Q2 2025. The company’s shares jumped more than 15% in ...
Shares in Accolade rose after the company reported a narrower second-quarter loss and higher revenue, beating analyst expectations. Shares were up 17% in premarket trading at $4.64.
SEATTLE, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal second quarter ended August 31, 2024.
Collaboration efforts between the Alliance Historical Society and the Alliance Preservation Society are off to an ...
A garment business tycoon, an owner of a local conglomerate, a celebrated local steel giant, a well-known bank and a woman ...
Arlington County officials are trumpeting a recent accolade that came to Alcova Heights Park. The county's Department of ...
A Brierley Hill-based bed retailer is celebrating after landing a top accolade. Dreamland was crowned Small Retailer of the ...
The local winemaking giant’s first private equity owner made a motza, the second lost it. The new brigade promises its reign ...
CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) has scheduled the release of its Fourth Quarter Fiscal 2024 results for ...